280 likes | 852 Vues
Isoimmunization Erythroblastosis Fetalis Hemolytic Disease of the Newborn. Zeev Weiner Director of Ultrasound in Obstetrics and Gynecology Lutheran Medical Center. Rh Isoimmunization. Rh Blood Group System: Cc D d Ee 40 other antigens: Du, Cw,…. The D antigen.
E N D
IsoimmunizationErythroblastosis FetalisHemolytic Disease of the Newborn Zeev Weiner Director of Ultrasound in Obstetrics and Gynecology Lutheran Medical Center
Rh Isoimmunization Rh Blood Group System: Cc Dd Ee 40 other antigens: Du, Cw,….
The D antigen In 85% the D antigen is present 55% heterozygous Sensitization occurs during blood transfusion and during pregnancy
The D antigen Isoimmunization is dose dependent 0.1 ml is sufficient ABO incompatibility confers partial protection!
Obstetrical risks for Rh isoimmunization Abortions (2-5%) – How early? Pregnancy and delivery (1.6%) Procedures: Amniocentesis Trauma
Rh Hemolytic Disease Mild: Fetal anemia with Hb>12-13g/dl. No sonographic findings.
Rh Hemolytic Disease Moderate: Fetal anemia with Hb between 7-12 g/dl Possible sonographic findings.
Rh Hemolytic Disease Severe: Anemia with Hb < 7g/dl Most of the time there are sonographic findings
Monitoring the sensitization When do we check anti-D titers? At the beginning, 28 wks, after birth What is a significant titer? Above 1:8-1:16 How accurate are the titers? …….. What is the meaning of very low titers and do we have to give prophylaxis? …….
Follow-up patients with sensitization Checking the Rh antigens of the father if negative no need to follow-up? Checking the Rh antigens of the fetus if negative definitely no need to follow-up
Follow-up patients with Rh isoimmunization Follow-up can start at 18 weeks gestation There are 3 options: Amniocentesis Cordocentesis Doppler
Amniocentesis for patients with Rh isoimmunization The Liley or the modified curves. Advantage: less complicated procedure Disadvantage: delta OD may not accurately correlate with the anemia
Cordocentesis for patients with Rh isoimmunization Blood sampling from the umbilical vein, hepatic or portal veins, intracardiac Advantage: more reliable, immediate option for treatment Disadvantage: higher risk
Doppler studies for patients with Rh isoimmunization Peak velocity of the middle cerebral artery (why not other vessels?) Advantage: non invasive Disadvantage: correlation with anemia is still questionable
Treatment of Fetal Anemia Indication: Hb < 10-11 g/L (Hct<30) or fetal hydrops Technique: Intraperitoneal, Intravascular (umbilical vein or others), Intracardiac
Treatment of Fetal Anemia Irradiated O- packed red cells (Hct=0.85-0.9) V =[(Hct-f - Hct-i)xEFWx120]: Hct-d Guidelines for repeat transfusion: 1% decline per day, Hct=25
Treatment of Severe Cases of Rh Isoimmunization Early transfusions starting at 16-18 wks A weekly high-dose of IVIG between 13-18 wks AID
Time and Mode of Delivery 33-34 wks with documented lung maturity 34-36 weeks with no need to document lung maturity No indication for a CS
Prevention of Rh Isoimmunization 300 micrograms of Anti-D Ab At 28 wks and within 72 hrs postpartum Protect against 15 ml of RBC